Latest4 months ago
Reinforcement doses of the Pfizer / BioNTech coronavirus vaccine show 95.6% efficacy in the phase 3 trial, according to the companies
[ad_1] The trial included more than 10,000 fully vaccinated people, over the age of 16, who were randomly given the booster dose of 30 micrograms of...
